• Exchange: Frankfurt
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

UV7:GR

0.006 EUR 0.004 200.00%

As of 13:00:18 ET on 12/17/2014.

Snapshot for Avexa Ltd (UV7)

Open: 0.006 Day's Range: 0.002 - 0.006 Volume: 0
Previous Close: 0.002 52wk Range: 0.001 - 0.016 1-Yr Rtn: -60.00%

Stock Chart for UV7

No chart data available.
  • UV7:GR 0.002
  • 1D
  • 1M
  • 1Y
0.002
Interactive UV7 Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for UV7

Current P/E Ratio (ttm) -
Estimated P/E(06/2015) -
Relative P/E vs. DAX -
Earnings Per Share (AUD) (ttm) -
Est. EPS (AUD) (06/2015) -
Est. PEG Ratio -
Market Cap (M EUR) 5.55
Shares Outstanding (M) 925.65
30 Day Average Volume 0
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 03/02/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for UV7

  • Revenue
  • Net Income (M/AUD)
  • Profit Margin (%)

Company Profile & Key Executives for UV7

Avexa Limited is a pharmaceutical company focused on the research and development of anti-infective drugs for such diseases as HIV, Hepatitis B, and vancomycin resistant bacterial infections.

Jonathan A V CoatesChief Scientific Ofcr/Interim CEOLee MitchellSecretary
M KlapakisController
More Company Profile & Key Executives for UV7

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil